Skip to main content

Peer Review reports

From: Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin

Original Submission
14 Sep 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
11 Nov 2022 Reviewed Reviewer Report
20 Nov 2022 Reviewed Reviewer Report
27 Nov 2022 Reviewed Reviewer Report
19 Dec 2022 Author responded Author comments - Takeshi Kawakami
Resubmission - Version 3
19 Dec 2022 Submitted Manuscript version 3
26 Dec 2022 Reviewed Reviewer Report
6 Jan 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
12 Jan 2023 Editorially accepted
20 Jan 2023 Article published 10.1186/s12885-023-10542-w

You can find further information about peer review here.

Back to article page